Invivyd (IVVD) Other Operating Expenses (2021 - 2025)
Invivyd (IVVD) reported Other Operating Expenses of $1.1 million for Q4 2025, up 57.46% on a YoY basis from $724000.0 in Q4 2024, and up 4.78% quarter-over-quarter from $1.1 million in Q3 2025.
Invivyd (IVVD) Other Operating Expenses (2021 - 2025) Analysis & Trends
Invivyd has reported Other Operating Expenses for 5 years, with the latest figure at $1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Other Operating Expenses rose 57.46% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.7 million (up 131.58% YoY), and the FY2025 full-year result was $3.7 million, up 131.58% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $1.1 million, up from $1.1 million in the prior quarter.
- The five-year high for Other Operating Expenses was $17.8 million in Q4 2022, with the low at -$600000.0 in Q4 2023.
- Historically, Other Operating Expenses has averaged $2.5 million across 5 years, with a median of $917000.0 in 2021.
- Annual changes were most pronounced in 2023 — Other Operating Expenses tumbled 103.38% — and 2025, when it surged 678.41%.
- Invivyd's Other Operating Expenses stood at $4.0 million in 2021, then surged by 344.32% to $17.8 million in 2022, then plunged by 103.38% to -$600000.0 in 2023, then surged by 220.67% to $724000.0 in 2024, then jumped by 57.46% to $1.1 million in 2025.
- The last three Other Operating Expenses figures came in at $1.1 million (Q4 2025), $1.1 million (Q3 2025), and $685000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 685,000.00 |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 724,000.00 |
| Sep 30, 2024 | 806,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Dec 31, 2023 | -600,000.00 |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 825,000.00 |
| Dec 31, 2022 | 17.77 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 1.00 Mn |